China-Biotics, Inc. Applies for Four Patents on Probiotic Formulations
SHANGHAI, July 31 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc.
(Nasdaq: CHBT ) ("China-Biotics", "the Company"), a leading Chinese firm
specializing in the manufacture, research, development, marketing and
distribution of probiotics products, today announced it has submitted
PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin
NES-ZIONA, Israel, June 30 /PRNewswire-FirstCall/ -- PROLOR Biotech, Inc. (OTC Bulletin Board: PBTH), formerly Modigene Inc., today announced that the U. S. Patent and Trademark Office (PTO) has issued two new patents
for the company's long-acting CTP-enhanced human growth hormone (hGH-CTP) and hu...
DNA2.0 Awarded US Patents for Breakthrough Gene Optimization Technology -- Company's Unique Algorithm Enables Expression Yields up to 50 Times Greater than Competing Approaches
The use of codon optimization in gene synthesis has long been misunderstood. DNA2.0 has cracked the code on optimizing sequence design and has been awarded two US patents
covering the technology. DNA2.0's approach goes beyond codon arrangement, so the company is introducing a new, more accurate c...
Access Pharmaceuticals Announces Granting of Two US Patents for MuGard(TM)
Commercial Launch of MuGard in Europe Ongoing
DALLAS, June 10 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) , announced today that the Company has received issue notifications from the United States Patent and Trademark Office that two US pat...
Sinobiopharma Applies For Two Chinese Patents For Cisatracurium Besylate
NANJING, China, May 21 /PRNewswire-FirstCall/ -- Sinobiopharma Inc. ("Sinobiopharma ", or "the Company") (OTC Bulletin Board: SNBP) is pleased to announce that it has applied for two Chinese patents
for its flagship product, Cisatracurim besylate, a pre-surgical skeletal muscle relaxant.
Resverlogix's Success in Inflammation Program Results in 2 Patents Filed
Novel small molecules illustrate potential cost effective approach for
TSX Exchange Symbol: RVX
CALGARY and ATLANTA, May 19 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is pleased to announce today that it has made s...
Immunotherapy-Based Provisional Patents Mark Significant Discovery
Quantum Immunologics announces the filing of two important provisional patent applications
TAMPA, Fla., March 31 /PRNewswire/ -- Quantum Immunologics, Inc. (QI), a Florida-based company specializing in cancer immunotherapy, has recently filed two provisional patent applications relating to th...
Confirmation of Bogoch Replikins Influenza Patents by Harvard-CDC and Scripps-Crucell Data
BOSTON, March 20 /PRNewswire/ -- Replikins, Ltd. announced today that data recently published from Harvard-CDC and Scripps-Crucell in Nature(1) and Science(2) confirms the 2001 discoveries by Dr. Samuel and Elenore Bogoch of peptides in the hemagglutinin unit of influenza, which they named Repliki...
InNexus Biotechnology Announces New Patents Protecting Novel Cell Penetrating DXL(TM) Antibodies
- Company Receives Allowance of Patent Claims in the U.S. and in India -
- InNexus Biotechnology CEO Highlighted in Nature Biotechnology -
BRITISH COLUMBIA, Canada, March 6 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc. (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsb...
Corgenix Receives Two Additional Patents on AtherOx(R) Technology
ISSUED IN U.S. AND EUROPE FOR TECHNOLOGY USED IN CORGENIX NEXT GENERATION PREDICTIVE CARDIOVASCULAR DIAGNOSTIC PRODUCT LINE
DENVER, Jan. 20 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits...
Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate
SAN MARINO, Calif., Dec. 16 /PRNewswire/ -- Epeius Biotechnologies
Corporation, a leader in tumor-targeted gene delivery systems, has received
two additional European patents
for the platform targeting technologies and
molecular designs that enable precision gene delivery to primary cancers and
Prometheus Strengthens Intellectual Property Portfolio with Newly Issued Patents for Thiopurine Metabolite Testing
SAN DIEGO, Oct. 30 /PRNewswire/ -- Prometheus Laboratories Inc., a
specialty pharmaceutical and diagnostics company, announced that the U.S.
Patent and Trademark Office (USPTO) has issued two separate patents
covering the technology for PROMETHEUS(R) Thiopurine Metabolites, a
diagnostic test t...
Cystic Fibrosis - Axentis Pharma Takes Over Patents and Continues Development of Innovative Platform Technology
ZURICH, Switzerland, June 26 /PRNewswire/ -- The rights to key patents
for an innovative screening tool for treatments for cystic fibrosis were
transferred today to Swiss biotech company Axentis Pharma AG. The company
has acquired the rights from an Austrian firm that has made a vital
Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane
Company Also Completes FDA Submission for Removal of Clinical Hold
BERKELEY HEIGHTS, N.J., June 10 /PRNewswire-FirstCall/ -- Genta
Incorporated (OTC Bulletin Board: GNTA) announced that the Company has
received notice of allowances for two major patents
from the European
Patent Office for i...
Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
NEW YORK, May 19 /PRNewswire-FirstCall/ -- Intellect Neurosciences,
Inc. (OTC Bulletin Board: ILNS), a biopharmaceutical company focused on
development of disease-modifying therapeutic agents for the treatment and
prevention of Alzheimer's disease (AD), announced today that it has entered
ImmunoVaccine Technologies Patents DepoVax(TM) Vaccine Platform
HALIFAX, April 30 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT),
a vaccine development company, unveiled today its DepoVax(TM) platform, a
novel depot vaccine delivery system used to increase the efficacy and
strength of vaccines. IVT has filed additional patents
to protect the
Occlutech Clarifies Statement Regarding Favourable Opinion Obtained From AIPPI With Regard to Patents Held by AGA Medical
JENA, Germany, April 17 /PRNewswire/ -- Occlutech GmbH, the leading
European manufacturer of cardiac occlusion devices today announced a
clarification of a recent news release.
In a news release dated February 8th, 2008, Occlutech stated that it
received an opinion from AIPPI the European "A...
Mercury Therapeutics Patents Filed Patents
Filed on Lead Compounds That Directly and Specifically Activate AMPK
WOBURN, Massachusetts, March 31 /PRNewswire/ -- Mercury Therapeutics,
Inc. (MTI), a company that discovers and develops orally active protein
kinase targeted drugs, announces that it h...
Cellectis Sues Precision BioSciences for Infringement of its Patents Concerning Meganuclease Technology
BIOCITECH PARK, ROMAINVILLE, France, March 13 /PRNewswire-FirstCall/ --
Cellectis SA (NYSE: ALCLS ), a world leader in rational genome engineering,
has announced today that it filed a patent infringement lawsuit against
Precision BioSciences, Inc. in the United States District Court for the
Alexion Acquires All Rights to OMRF Patents Related to Soliris(R)
CHESHIRE, Conn., Feb. 14 /PRNewswire-FirstCall/ -- The Oklahoma Medical
Research Foundation ("OMRF") and Alexion Pharmaceuticals, Inc. ("Alexion,"
Nasdaq: ALXN) today announced that Alexion has agreed to acquire from OMRF
all rights to certain patents
related to complement-inhibition technolog...
iCAD, Inc. Awarded Two Additional Patents for Its Computer-Aided Detection Technology
NASHUA, N.H., Dec. 10 /PRNewswire-FirstCall/ -- iCAD, Inc. (Nasdaq:
ICAD), an industry-leading provider of Computer-Aided Detection (CAD)
solutions for the early identification of cancer, today announced that two
U.S. Patents, No. 7,298,877 and No. 7,308,126, have recently been granted
to the ...
Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge
COLUMBIA, Md., Nov. 1 /PRNewswire-FirstCall/ -- Martek Biosciences
Corporation (Nasdaq: MATK ) today announced that a judge in the United
States District Court in Wilmington, Delaware, has ruled on various
post-trial motions and will enter a permanent injunction in Martek's favor
against the ...
ASCP Joins ACLU Lawsuit Opposing Gene Patents
The American Society for Clinical Pathology (ASCP) has joined the American Civil Liberties Union (ACLU) in a lawsuit challenging the legality of patents
on human genes -- specifically, patents
covering the BRCA1 and BRCA2 genes, which are associated with breast and ovarian cancer. The lawsuit wa...
NanoLogix Inc. to Exhibit at The American Society for Microbiology (ASM) General Meeting in Philadelphia; Announces Two New Patents
HUBBARD, Ohio, May 5 /PRNewswire-FirstCall/ -- NanoLogix, Inc. (Pink Sheets: NNLX) NanoLogix personnel will display the company's BNP(TM) rapid-detection technology at booth 749 during the 109th Annual ASM Meeting to be held at the Pennsylvania Convention Center in Philadelphia May 17th - 21st. Th...
Sinobiopharma Secures Rights to Seven Key Patents
NANJING, China, April 27 /PRNewswire-FirstCall/ -- Sinobiopharma Inc. ("Sinobiopharma ", or "the Company") (OTC Bulletin Board: SNBP) is pleased to announce that it has secured rights to seven key patents
from Company CEO Dr. Lequn Huang and the patents' co-holders. The patents
that will significa...
Shire Files Lawsuit Against Natco Pharma for Infringement of FOSRENOL(R) (lanthanum carbonate) Patents
PHILADELPHIA, April 2 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP,
NASDAQ: SHPGY ) announces that it has filed a lawsuit in the U.S. District
Court for the Southern District of New York against Natco Pharma Limited
("Natco") for infringement of two of Shire's patents: U.S. Patent No.
Shire Files Lawsuit Against Barr Laboratories for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patents
PHILADELPHIA, Pennsylvania and DUBLIN, Ireland, March 16
/PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY ) announces that
it has filed a lawsuit in the U.S. District Court of the Southern District of
New York against Barr Laboratories, Inc. ("Barr") for infringement of three
WIPO Panel Rules Boston Scientific Liberte(R) and TAXUS(R) Liberte(R) Stents Do Not Infringe Medinol Patents
NATICK, Mass., May 5 /PRNewswire-FirstCall/ -- Boston Scientific
Corporation (NYSE: BSX ) announced today that a World Intellectual Property
Organization (WIPO) arbitration panel has issued its ruling in an
arbitration between the Company and Medinol, Ltd. Medinol, which had
requested the arb...
Microchip Biotechnologies, Inc. Enters Into License Arrangement With GE Healthcare for Fundamental Microfluidic Patents
DUBLIN, Calif., April 22 /PRNewswire/ -- Microchip Biotechnologies,
Inc. (MBI) announces that it has entered into a multi-patent license
agreement with GE Healthcare that significantly enhances MBI's intellectual
property portfolio supporting the development of lab-on-a-chip devices. The
U.S. PTO Reexamining Lumenis Patents
Lumenis Patent Litigation with Alma Lasers Stayed
CAESAREA, Israel, March 26 /PRNewswire/ -- Alma Lasers Ltd., a global
leader in aesthetic laser, light-based, and radiofrequency systems,
announces important developments in its patent dispute with Lumenis Ltd.,
which is being litiga...
Rosetta Genomics Announces Allowance of Two Additional microRNA Patents
Allowances Further Strengthen Company's Leading microRNA Intellectual Property Position Company's microRNA Patent Portfolio now Includes 2 Issued Patents, 2 Allowed Patents, and More Than 60 Pending Patent Applications
REHOVOT, Israel and NORTH BRUNSWICK, New Je...
Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
NEW YORK, Sept. 10 /PRNewswire/ -- In a major victory for its client,
Applera Corporation, a global leader in DNA sequencing technologies, Weil,
Gotshal & Manges LLP won a summary judgment ruling invalidating three key
contested life sciences patents. In the action, Enzo Biochem, Inc., had
WARF licenses patents for new glaucoma drug treatment
Madison, Wis. The Wisconsin Alumni Research Foundation has licensed three patents
for developing a new drug that targets the underlying cause of glaucoma, a group of diseases that can lead to blindness.
are based on research conducted by Paul Kaufman , a University of Wiscons...
Scientist takes back patents and develops product others ignored
Madison, Wis. Mark Cook, a tenured animal sciences professor at the University of Wisconsin-Madison, had seen his patents
get licensed out to several businesses, only to sit on the shelves.
Hed been working since the mid 1980s on biotechnology that was was not being promoted by any of the bus...
Drug innovation beats marketing, patents and mergers
In a recent BusinessWeek article profiling the significant rise in valuation of Genentech (NYSE: DNA), the authors point out that it is true product innovation through focused R&D efforts that's currently paying off in terms of investor confidence and resulting market valuation.
Tommy Thompson's ID chip, California firm to use WARF's patents and more ...
Former Governor Secretary Tommy Thompson announced last week that he is planning to have a radio frequency id chip implanted in his arm that will provide access to his electronic medical records. Meanwhile over at the UW, the Wisconsin Alumni Research Foundation announced that it has licensed Cali...
Request to re-examine WARF stem cell patents escalates war of words
Madison, Wis. - The legal challenge to stem cell patents
held by the Wisconsin Alumni Research Foundation has escalated the war of words between two states -Wisconsin and California - with both questioning the other's financial motivations.
The most recent exchange came after the Public Pa...
With patents and research tools, when is private really public?
Editor's note: This article first appeared in Genetic Engineering News (Volume 26, No. 11)
There is good news for inventors. Using an invention secretly in one's own shop, even for a period longer than a year, will not by itself cause a court to invalidate a patent filed later to protect t...
Father of life patents downplays historic role
Madison, Wis. - Ananda Chakrabarty is modest about the role he played in sparking the American biotechnology industry, but others are willing to do the boasting for him.
Chakrabarty Chakrabarty, the first person to successfully patent life forms, visited Wisconsin this week to lecture stu...
WARF stem cell patents to be re-examined
Madison, Wis. - As expected, the United States Patent and Trademark Office has granted requests from a consumer group and public service patent attorneys to re-examine three patents
on human embryonic stem cells held by the Wisconsin Alumni Research Foundation (WARF).
The challenges, brou...